Your browser doesn't support javascript.
loading
A Metabolomics Study on the Bone Protective Effects of a Lignan-Rich Fraction From Sambucus Williamsii Ramulus in Aged Rats.
Xiao, Hui-Hui; Sham, Tung-Ting; Chan, Chi-On; Li, Meng-Heng; Chen, Xi; Wu, Qing-Chang; Mok, Daniel Kam-Wah; Yao, Xin-Sheng; Wong, Man-Sau.
Affiliation
  • Xiao HH; State Key Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation), Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen, China.
  • Sham TT; Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hong Kong, China.
  • Chan CO; State Key Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation), Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen, China.
  • Li MH; Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hong Kong, China.
  • Chen X; Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hong Kong, China.
  • Wu QC; School of Biotechnology, East China University of Science and Technology, Shanghai, China.
  • Mok DK; Institute of Traditional Chinese Medicine & Natural Products, Jinan University, Guangzhou, China.
  • Yao XS; State Key Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation), Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen, China.
  • Wong MS; Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hong Kong, China.
Front Pharmacol ; 9: 932, 2018.
Article in En | MEDLINE | ID: mdl-30186170
ABSTRACT
The lignan-rich fraction (SWR) of Sambucus Williamsii Ramulus, a folk herbal medicine in China for treatment of bone diseases, has previously reported to exert protective effects on bone without exerting uterotrophic effects in ovariectomized (OVX) mice. The aim of the present study was to identify the potential metabolites and the associated metabolic pathways that contribute to the beneficial effects of SWR on bone in vivo. Aged female Sprague Dawley rats (9 months old) were either sham-operated or ovariectomized for 12 weeks, before receiving treatment for another 12 weeks with the following treatment groups (n = 12 each) vehicle (Sham), vehicle (OVX), Premarin (130 µg/kg) or low (57 mg/kg), medium (114 mg/kg), and high (228 mg/kg) doses of SWR. The results showed that SWRH significantly suppressed bone loss, improved bone micro-architecture and increased bone strength on tibia without stimulating uterus weight gain in OVX rats. Premarin exerted similar bone protective effects as SWRH but elicited uterotrophic effects in OVX rats. The metabolic profiles of serum samples were analyzed by using ultra-performance liquid chromatography quadrupole time-of flight mass spectrometry and gas chromatography time-of flight mass spectrometry, and the metabolites that were significantly altered were identified by multivariate statistical analysis. Our study indicated that SWRH effectively restored the changes of 26 metabolites induced by estrogen-deficiency in OVX rats, which related to lipids, amino acids, tryptophan metabolisms, and anti-oxidative system. A subsequent validation showed that the serum level of superoxide dismutase and catalase were indeed up-regulated, while the serotonin level in a tryptophan hydroxylase 1 (TPH1) high expressing cells (rats RBL-2H3 cells) was down regulated after treatment with SWR. The results also suggested that the gut-microbiota may play an important role on the bone protective effects of SWR. The current study provides insight for understanding the unique mechanism of actions of SWR that might be involved in achieving bone protective effects in vivo.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2018 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2018 Document type: Article Affiliation country: China